日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Value of gene mutation in the prognosis and treatment of multiple myeloma]

[基因突变在多发性骨髓瘤预后和治疗中的价值]

Cheng, L L; Zhuang, J L

Hebb's Vision: The Structural Underpinnings of Hebbian Assemblies

赫布的愿景:赫布式集会的结构基础

Wagner-Carena, J; Kate, S; Riordan, T; Abbasi-Asl, R; Aman, J; Amster, A; Bodor, A L; Brittain, D; Buchanan, J A; Buice, M A; Bumbarger, D J; Collman, F; da Costa, N M; Denman, D J; de Vries, Sej; Joyce, E; Kapner, D; King, C W; Larkin, J D; Lecoq, J; Mahalingam, G; Millman, D; Mölter, J; Morrison, C; Reid, R C; Schneider-Mizell, C M; Daniel, S; Suckow, S; Takasaki, K T; Takeno, M; Torres, R; Vumbaco, D; Waters, J; Wyrick, D G; Yin, W; Zhuang, J; Mihalas, S; Berteau, S

[Application of Rotarex catheter system in femoropopliteal artery stenosis accompanied with thrombosis]

【Rotarex导管系统在伴有血栓的股腘动脉狭窄中的应用】

Zhuang, J M; Li, T R; Li, X; Luan, J Y; Wang, C M; Feng, Q C; Han, J T

[The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment]

【新诊断的多发性骨髓瘤合并肾功能不全患者肾脏反应的影响因素】

Song, Y H; Zhang, F J; Hu, R R; Chen, M; Yang, C; Wang, W; Qin, Y; Zhou, D B; Zhuang, J L

[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]

[年轻骨髓增生性肿瘤患者的临床和遗传特征]

Zhang, M Y; Bao, M; Shi, D Y; Shi, H X; Liu, X L; Xu, N; Duan, M H; Zhuang, J L; Du, X; Qin, L; Hui, W H; Liang, R; Wang, M F; Chen, Y; Li, D Y; Yang, W; Tang, G S; Zhang, W H; Kuang, X; Su, W; Han, Y Q; Chen, L M; Xu, J H; Liu, Z G; Huang, J; Zhao, C T; Tong, H Y; Hu, J D; Chen, C Y; Chen, X Q; Xiao, Z J; Jiang, Q

[Classic hairy cell leukemia with MAP2K1 mutation: a case report]

【伴有MAP2K1突变的经典型毛细胞白血病:病例报告】

Wei, C; Cai, H; Jiang, X Y; Wang, X; Zhou, D B; Zhuang, J L

[Analysis of the efficacy and survival of ixazomib-containing regimens in patients with refractory and relapsed multiple myeloma]

[伊沙佐米方案治疗难治性复发性多发性骨髓瘤患者的疗效和生存分析]

Yang, C; Zhuang, J L

[Clinical characteristics and prediction model of early death in severe/very severe aplastic anemia with immunosuppressive therapy]

[接受免疫抑制治疗的重度/极重度再生障碍性贫血患者的临床特征及早期死亡预测模型]

Chen, M; Zhuang, J L; Yang, C; Wang, W; Zhang, Y; Zhang, L; Zhao, D Q; Feng, J; Li, J; Zhou, D B; Han, B

[Analysis of the clinical characteristics and prognosis of 36 cases of newly diagnosed multiple myeloma patients with bone marrow monoclonal plasma cell ratio of less than 10]

【骨髓单克隆浆细胞比例小于10的36例新诊断多发性骨髓瘤患者的临床特征及预后分析】

Zhao, J T; Jiang, X Y; Yang, C; Chen, M; Lan, X L; Du, J H; Zhou, D B; Zhuang, J L

[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms]

[中国费城染色体阴性骨髓增生性肿瘤患者的健康相关生活质量及其相关变量]

Bao, M; Shi, D Y; Shi, H X; Liu, X L; Duan, M H; Zhuang, J L; Du, X; Qin, L; Hui, W H; Liang, R; Wang, M F; Chen, Y; Li, D Y; Yang, W; Tang, G S; Zhang, W H; Kuang, X; Su, W; Han, Y Q; Chen, L M; Xu, J H; Liu, Z G; Huang, J; Zhao, C T; Tong, H Y; Hu, J D; Chen, C Y; Chen, X Q; Xiao, Z J; Jiang, Q